Moody’s revises Indiana University Health’s outlook to positive

Moody’s Investors Service has assigned “Aa3” ratings to Indianapolis-based Indiana University Health’s following proposed bonds:

Advertisement

  • $163 million of series 2016A bonds
  • $50 million of series 2016B bonds
  • $50 million of series 2016C bonds

In addition, Moody’s affirmed IU Health’s “Aa3” ratings on $1.1 billion of debt.

The rating assignment is based on several factors, including IU Health’s sustained margins and its leading market position in the greater Indianapolis area and the state of Indiana.

The outlook is revised to positive, reflecting Moody’s expectations that liquidity and margins will stay strong.

More articles on healthcare finance:
Kaiser, New York Times identify most problematic medical bills: 5 things to know
Aver raises $13.6M to expand healthcare reimbursement platform
McKesson Technology Solutions CMO: Positioning the C-suite to master value-based reimbursement models


 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.